Steward Partners Investment Advisory, LLC
Position in NVCT — Nuvectis Pharma, Inc.
CIK 1723397
STAMFORD, CT
Position in NVCT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$773
+$18 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Steward Partners Investment Advisory, LLC holds $46,353,299 across 170 Biotechnology names. NVCT ranks #145 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
338,246 | $11,006,524 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,863 | $7,976,544 | |
| 3 | ARGX |
Argenx SE
|
9,371 | $6,843,172 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,620 | $3,569,596 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
35,027 | $1,978,675 | |
| 6 | CRMD |
CorMedix Inc.
|
229,465 | $1,558,067 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
146,453 | $1,176,017 | |
| 8 | NKTR |
Nektar Therapeutics
|
15,526 | $1,117,095 |
All Filings in NVCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $773 | 100 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $755 | 100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $602 | 100 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $747 | 100 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $977 | 100 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $541 | 100 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $629 | 100 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $633 | 100 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||